Suppr超能文献

P53免疫组化评分:肝细胞癌切除术后患者的独立预后标志物

P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.

作者信息

Qin Lun-Xiu, Tang Zhao-You, Ma Zeng-Chen, Wu Zhi-Quan, Zhou Xin-Da, Ye Qing-Hai, Ji Yuan, Huang Li-Wen, Jia Hu-Liang, Sun Hui-Chuan, Wang Lu

机构信息

Liver Cancer Institute & Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China.

出版信息

World J Gastroenterol. 2002 Jun;8(3):459-63. doi: 10.3748/wjg.v8.i3.459.

Abstract

AIM

To confirm if p53 mutation could be a routine predictive marker for the prognosis of hepatocellular carcinoma (HCC) patients.

METHODS

Two hundreds and forty-four formalin-fixed paraffin-embedded tumor samples of the patients with HCC receiving liver resection were detected for nuclear accumulation of p53. The percent of P53 immunoreactive tumor cells was scored as 0 to 3+ in P53 positive region (<10% -, 10-30% +, 31-50% ++, >50% +++). Proliferating cell nuclear antigen (PCNA) and some clinicopathological characteristics, including patients' sex, preoperative serum AFP level, tumor size, capsule, vascular invasion (both visual and microscopic), and Edmondson grade were also evaluated.

RESULTS

In univariate COX harzard regression model analysis, tumor size, capsule status, vascular invasion, and p53 expression were independent factors that were closely related to the overall survival (OS) rates of HCC patients. The survival rates of patients with 3+ for P53 expression were much lower than those with 2+ or + for P53 expression. Only vascular invasion (P<0.05) and capsule (P<0.01) were closely related to the disease-free survival (DFS) of HCC patients. In multivariate analysis, p53 overexpression (RI 0.5456, P<0.01) was the most significant factor associated with the OS rates of patients after HCC resection, while tumor size (RI 0.5209, P<0.01), vascular invasion (RI 0.5271, P<0.01) and capsule (RI-0.8691, P<0.01) were also related to the OS. However, only tumor capsular status was an independent predictive factor (P<0.05) for the DFS. No significant prognostic value was found in PCNA-LI, Edmondson's grade, patients' sex and preoperative serum AFP level.

CONCLUSION

Accumulation of p53 expression, as well as tumor size, capsule and vascular invasion, could be valuable markers for predicting the prognosis of HCC patients after resection. The quantitative immunohistochemical scoring for P53 nuclear accumulation might be more valuable for predicting prognosis of patients after HCC resection than the common qualitative analysis.

摘要

目的

确认p53突变是否可作为肝细胞癌(HCC)患者预后的常规预测标志物。

方法

对244例接受肝切除术的HCC患者的福尔马林固定石蜡包埋肿瘤样本进行p53核聚集检测。在p53阳性区域(<10%为-,10%-30%为+,31%-50%为++,>50%为+++),将P53免疫反应性肿瘤细胞百分比评分为0至3+。还评估了增殖细胞核抗原(PCNA)以及一些临床病理特征,包括患者性别、术前血清甲胎蛋白水平、肿瘤大小、包膜、血管侵犯(肉眼和显微镜下)以及Edmondson分级。

结果

在单因素COX风险回归模型分析中,肿瘤大小、包膜状态、血管侵犯和p53表达是与HCC患者总生存率(OS)密切相关的独立因素。P53表达为3+的患者生存率远低于P53表达为2+或+的患者。仅血管侵犯(P<0.05)和包膜(P<0.01)与HCC患者无病生存率(DFS)密切相关。在多因素分析中,p53过表达(相对指数0.5456,P<0.01)是与HCC切除术后患者OS率相关的最显著因素,而肿瘤大小(相对指数0.5209,P<0.01)、血管侵犯(相对指数0.5271,P<0.01)和包膜(相对指数-0.8691,P<0.01)也与OS相关。然而,只有肿瘤包膜状态是DFS的独立预测因素(P<0.05)。在PCNA-LI、Edmondson分级、患者性别和术前血清甲胎蛋白水平方面未发现显著的预后价值。

结论

p53表达的积累以及肿瘤大小、包膜和血管侵犯可能是预测HCC患者切除术后预后的有价值标志物。P53核积累的定量免疫组化评分可能比普通定性分析对预测HCC切除术后患者的预后更有价值。

相似文献

2
Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
World J Gastroenterol. 2005 May 14;11(18):2709-13. doi: 10.3748/wjg.v11.i18.2709.
4
Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.
6
A morpho-molecular prognostic model for hepatocellular carcinoma.
Br J Cancer. 2012 Jul 10;107(2):334-9. doi: 10.1038/bjc.2012.230. Epub 2012 Jun 19.
8
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.
9
Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France.
Int J Cancer. 1997 Dec 19;74(6):614-9. doi: 10.1002/(sici)1097-0215(19971219)74:6<614::aid-ijc10>3.0.co;2-5.
10
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Arch Surg. 2000 Nov;135(11):1329-33. doi: 10.1001/archsurg.135.11.1329.

引用本文的文献

3
Precision medicine: In need of guidance and surveillance.
World J Gastroenterol. 2017 Jul 28;23(28):5045-5050. doi: 10.3748/wjg.v23.i28.5045.
5
Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.
Tumour Biol. 2014 Jul;35(7):7163-75. doi: 10.1007/s13277-014-1874-4. Epub 2014 Apr 25.
6
Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis.
Hepatobiliary Surg Nutr. 2014 Feb;3(1):11-7. doi: 10.3978/j.issn.2304-3881.2014.01.03.
8
Targeting the HGF-cMET Axis in Hepatocellular Carcinoma.
Int J Hepatol. 2013;2013:341636. doi: 10.1155/2013/341636. Epub 2013 Mar 31.
9
Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.
Chin J Cancer Res. 2011 Dec;23(4):245-53. doi: 10.1007/s11670-011-0245-6.

本文引用的文献

2
Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential.
World J Gastroenterol. 2001 Oct;7(5):597-601. doi: 10.3748/wjg.v7.i5.597.
3
Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver.
World J Gastroenterol. 2001 Aug;7(4):579-82. doi: 10.3748/wjg.v7.i4.579.
4
Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice.
World J Gastroenterol. 2001 Aug;7(4):532-6. doi: 10.3748/wjg.v7.i4.532.
5
Hepatocellular carcinoma--cause, treatment and metastasis.
World J Gastroenterol. 2001 Aug;7(4):445-54. doi: 10.3748/wjg.v7.i4.445.
6
7
Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis.
World J Gastroenterol. 2001 Apr;7(2):285-8. doi: 10.3748/wjg.v7.i2.285.
8
Expressions of ICAM-1 and its mRNA in sera and tissues of patients with hepatocellular carcinoma.
World J Gastroenterol. 2001 Feb;7(1):120-5. doi: 10.3748/wjg.v7.i1.120.
9
Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma.
World J Gastroenterol. 2000 Oct;6(5):693-698. doi: 10.3748/wjg.v6.i5.693.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验